Your browser doesn't support javascript.
loading
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial).
Lombardi, Giuseppe; Del Bianco, Paola; Brandes, Alba A; Eoli, Marica; Rudà, Roberta; Ibrahim, Toni; Lolli, Ivan; Rizzato, Simona; Daniele, Bruno; Pace, Andrea; Pasqualetti, Francesco; Caccesse, Mario; Bergo, Eleonora; Magni, Giovanna; De Salvo, Gian Luca; Zagonel, Vittorina.
Afiliação
  • Lombardi G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Del Bianco P; Clinical Research Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Brandes AA; Medical Oncology Department, AUSL/IRCCS, Neurological Science Institute, Bologna, Italy.
  • Eoli M; Molecolar Neuro-Oncology Unit, IRCCS Foundation, "Carlo Besta" Neurological Institute, Milan, Italy.
  • Rudà R; Department of Neuro-Oncology, University of Turin and City of Health and Science Hospital, Turin, Italy.
  • Ibrahim T; Osteoncology and Rare Tumors Center, IRST-IRCCS "Dino Amadori", Meldola, Italy.
  • Lolli I; Medical Oncology Unit, IRCCS Saverio de Bellis Hospital, Castellana Grotte, Bari, Italy.
  • Rizzato S; Department of Oncology, Santa Maria della Misericordia University Hospital, Udine, Italy.
  • Daniele B; Oncology Unit, Ospedale del Mare, Napoli, Italy.
  • Pace A; Neuroncology Unit, IRCCS Regina Elena Cancer Institute, Roma, Italy.
  • Pasqualetti F; Radiotherapy Unit, University Hospital S. Chiara, Pisa, Italy.
  • Caccesse M; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Bergo E; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Magni G; Clinical Research Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • De Salvo GL; Clinical Research Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. Electronic address: gianluca.desalvo@iov.veneto.it.
  • Zagonel V; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Eur J Cancer ; 155: 179-190, 2021 09.
Article em En | MEDLINE | ID: mdl-34388515
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Glioblastoma / Lomustina Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Aspecto: Patient_preference Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Glioblastoma / Lomustina Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Aspecto: Patient_preference Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido